In Vivo Imaging of Molecularly Targeted Phage

Rapid identification of in vivo affinity ligands would have far-reaching applications for imaging specific molecular targets, in vivo systems imaging, and medical use. We have developed a high-throughput method for identifying and optimizing ligands to map and image biologic targets of interest in...

Full description

Bibliographic Details
Main Authors: Kimberly A. Kelly, Peter Waterman, Ralph Weissleder
Format: Article
Language:English
Published: Elsevier 2006-12-01
Series:Neoplasia: An International Journal for Oncology Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1476558606801065
id doaj-49853ab331d046f88f82a00a3f8f767a
record_format Article
spelling doaj-49853ab331d046f88f82a00a3f8f767a2020-11-24T22:24:05ZengElsevierNeoplasia: An International Journal for Oncology Research1476-55861522-80022006-12-018121011101810.1593/neo.06610In Vivo Imaging of Molecularly Targeted PhageKimberly A. KellyPeter WatermanRalph Weissleder Rapid identification of in vivo affinity ligands would have far-reaching applications for imaging specific molecular targets, in vivo systems imaging, and medical use. We have developed a high-throughput method for identifying and optimizing ligands to map and image biologic targets of interest in vivo. We directly labeled viable phage clones with far-red fluorochromes and comparatively imaged them in vivo by multichannel fluorescence ratio imaging. Using Secreted Protein Acidic and Rich in Cysteine (osteonectin) and vascular cell adhesion molecule-1 as model targets, we show that: 1) fluorescently labeled phage retains target specificity on labeling; 2) in vivo distribution can be quantitated (detection thresholds of ~ 300 phage/mm3 tissue) throughout the entire depth of the tumor using fluorescent tomographic imaging; and 3) fluorescently labeled phage itself can serve as a replenishable molecular imaging agent. The described method should find widespread application in the rapid in vivo discovery and validation of affinity ligands and, importantly, in the use of fluorochrome-labeled phage clones as in vivo imaging agents. http://www.sciencedirect.com/science/article/pii/S1476558606801065Phage displayscreeningdrug discoverymolecular imagingsystems biology
collection DOAJ
language English
format Article
sources DOAJ
author Kimberly A. Kelly
Peter Waterman
Ralph Weissleder
spellingShingle Kimberly A. Kelly
Peter Waterman
Ralph Weissleder
In Vivo Imaging of Molecularly Targeted Phage
Neoplasia: An International Journal for Oncology Research
Phage display
screening
drug discovery
molecular imaging
systems biology
author_facet Kimberly A. Kelly
Peter Waterman
Ralph Weissleder
author_sort Kimberly A. Kelly
title In Vivo Imaging of Molecularly Targeted Phage
title_short In Vivo Imaging of Molecularly Targeted Phage
title_full In Vivo Imaging of Molecularly Targeted Phage
title_fullStr In Vivo Imaging of Molecularly Targeted Phage
title_full_unstemmed In Vivo Imaging of Molecularly Targeted Phage
title_sort in vivo imaging of molecularly targeted phage
publisher Elsevier
series Neoplasia: An International Journal for Oncology Research
issn 1476-5586
1522-8002
publishDate 2006-12-01
description Rapid identification of in vivo affinity ligands would have far-reaching applications for imaging specific molecular targets, in vivo systems imaging, and medical use. We have developed a high-throughput method for identifying and optimizing ligands to map and image biologic targets of interest in vivo. We directly labeled viable phage clones with far-red fluorochromes and comparatively imaged them in vivo by multichannel fluorescence ratio imaging. Using Secreted Protein Acidic and Rich in Cysteine (osteonectin) and vascular cell adhesion molecule-1 as model targets, we show that: 1) fluorescently labeled phage retains target specificity on labeling; 2) in vivo distribution can be quantitated (detection thresholds of ~ 300 phage/mm3 tissue) throughout the entire depth of the tumor using fluorescent tomographic imaging; and 3) fluorescently labeled phage itself can serve as a replenishable molecular imaging agent. The described method should find widespread application in the rapid in vivo discovery and validation of affinity ligands and, importantly, in the use of fluorochrome-labeled phage clones as in vivo imaging agents.
topic Phage display
screening
drug discovery
molecular imaging
systems biology
url http://www.sciencedirect.com/science/article/pii/S1476558606801065
work_keys_str_mv AT kimberlyakelly invivoimagingofmolecularlytargetedphage
AT peterwaterman invivoimagingofmolecularlytargetedphage
AT ralphweissleder invivoimagingofmolecularlytargetedphage
_version_ 1725762304503447552